AI and CRISPR: Revolutionizing Genome Editing and Precision Medicine
CRISPR-based genome editing technologies have revolutionized gene study and medical treatment by enabling precise DNA alterations. AI integration has enhanced these technologies’ precision, efficiency, and affordability, particularly for diseases like Sickle Cell Anemia and Thalassemia. AI models such as DeepCRISPR, CRISTA, and DeepHF optimize guide RNA (gRNA) design for CRISPR-Cas systems by considering factors like genomic context and off-target effects.